This inventor holds 3 USPTO granted patents. Top assignee: Vical Incorporated. Active years: 1996-2005.
Location History:
- Encinitas, CA (US) (1996)
- San Diego, CA (US) (1996 - 2005)
Company Filing History:
Years Active: 1996-2005
Title: Innovations and Contributions of Inventor Jennifer Meek
Introduction
Jennifer Meek is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions and methods for delivering therapeutics. With a total of 3 patents to her name, her work has the potential to impact various medical applications.
Latest Patents
One of her latest patents is titled "Compositions and methods for in vivo delivery of polynucleotide-based therapeutics." This invention focuses on improving the expression of exogenous polypeptides in vertebrate cells through the delivery of polynucleotides. The patent highlights the use of specific salts, such as sodium and potassium salts of phosphate, along with auxiliary agents like detergents and surfactants, to enhance the delivery process.
Another notable patent is "Process for reducing RNA concentration in a mixture of biological material." This invention outlines a method for reducing RNA concentration by filtering a biological mixture through diatomaceous earth material. The process effectively lowers the RNA concentration, making it a valuable technique in biological research and applications.
Career Highlights
Jennifer Meek is currently associated with Vical Incorporated, where she continues to innovate and develop new solutions in biotechnology. Her work at Vical has positioned her as a key player in the industry, contributing to advancements in therapeutic delivery systems.
Collaborations
Throughout her career, Jennifer has collaborated with talented individuals such as Magda Marquet and Gregg Budahazi. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Jennifer Meek's contributions to biotechnology through her patents and work at Vical Incorporated demonstrate her commitment to advancing medical science. Her innovative approaches to therapeutic delivery and RNA concentration reduction highlight her role as a leading inventor in her field.